SGN-75

· Seagen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGN-75, covering 2014-01-28 to 2014-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma [Phase 1]